nach oben

Erschienen in:

01.10.2011

Immunologically restricted patients exhibit a pronounced inflammation and inadequate response to hypoxia in fracture hematomas

verfasst von: Paula Hoff, T. Gaber, K. Schmidt-Bleek, U. Sentürk, C. L. Tran, K. Blankenstein, S. Lütkecosmann, J. Bredahl, H. J. Schüler, P. Simon, G. Wassilew, F. Unterhauser, G. R. Burmester, G. Schmidmaier, C. Perka, G. N. Duda, F. Buttgereit

Erschienen in: Immunologic Research | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

For patients who are known to have an impaired immune system, bone healing is often impaired. Therefore, it has been suggested that an effectively functioning immune system will have an influence on the quality of bone healing. Here, we demonstrate that cells within the fracture hematoma of immunologically restricted patients (1) exhibit a disturbed osteogenic differentiation (normal SPP1 but diminished RUNX2 expression), (2) show a strong inflammatory reaction (high IL8 and CXCR4), and (3) react on local hypoxia (high expression of HIF1A) but with inadequate target gene responses (diminished LDHA and PGK1 expression). Thus, it is already within the early inflammatory phase of fracture healing that the local gene expression in fracture hematomas of immunologically restricted patients points toward a critical regeneration.

Schmidmaier G, Schwabe P, Wildemann B, Haas NP. Use of bone morphogenetic proteins for treatment of non-unions and future perspectives. Injury. 2007;38(Suppl 4):S35–41.PubMedCrossRef

Taguchi K, Ogawa R, Migita M, Hanawa H, Ito H, Orimo H. The role of bone marrow-derived cells in bone fracture repair in a green fluorescent protein chimeric mouse model. Biochem Biophys Res Commun. 2005;331:31–6.PubMedCrossRef

Phillips AM. Overview of the fracture healing cascade. Injury. 2005;36(Suppl 3):S5–7.PubMedCrossRef

Schindeler A, McDonald MM, Bokko P, Little DG. Bone remodeling during fracture repair: the cellular picture. Semin Cell Dev Biol. 2008;19:459–66.PubMedCrossRef

Kolar P, Schmidt-Bleek K, Schell H, Gaber T, Toben D, Schmidmaier G, Perka C, Buttgereit F, Duda GN. The early fracture hematoma and its potential role in fracture healing. Tissue Eng Part B Rev. 2010;16:427–34.PubMedCrossRef

Gaber T, Dziurla R, Tripmacher R, Burmester GR, Buttgereit F. Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do!. Ann Rheum Dis. 2005;64:971–80.PubMedCrossRef

Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, Firestein GS, Gerber HP, Ferrara N, Johnson RS. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell. 2003;112:645–57.PubMedCrossRef

Gaber T, Haupl T, Sandig G, Tykwinska K, Fangradt M, Tschirschmann M, Hahne M, Dziurla R, Erekul K, Lautenbach M, Kolar P, Burmester GR, Buttgereit F. Adaptation of human CD4+ T cells to pathophysiological hypoxia: a transcriptome analysis. J Rheumatol. 2009;36:2655–69.PubMedCrossRef

Epari DR, Kassi JP, Schell H, Duda GN. Timely fracture-healing requires optimization of axial fixation stability. J Bone Joint Surg Am. 2007;89:1575–85.PubMedCrossRef

10.

Lienau J, Schell H, Epari DR, Schutze N, Jakob F, Duda GN, Bail HJ. CYR61 (CCN1) protein expression during fracture healing in an ovine tibial model and its relation to the mechanical fixation stability. J Orthop Res. 2006;24:254–62.PubMedCrossRef

11.

Bogoch ER, Moran EL. Bone abnormalities in the surgical treatment of patients with rheumatoid arthritis. Clin Orthop Relat Res. 1999;366:8–21.PubMedCrossRef

12.

Dominiak B, Oxberry W, Chen P. Study on a nonhealing fracture from a patient with systemic lupus erythematosus and its pathogenetic mechanisms. Ultrastruct Pathol. 2005;29:107–20.PubMedCrossRef

13.

Follak N, Kloting I, Merk H. Influence of diabetic metabolic state on fracture healing in spontaneously diabetic rats. Diabetes Metab Res Rev. 2005;21:288–96.PubMedCrossRef

14.

Kidder LS, Chen X, Schmidt AH, Lew WD. Osteogenic protein-1 overcomes inhibition of fracture healing in the diabetic rat: a pilot study. Clin Orthop Relat Res. 2009;467:3249–56.PubMedCrossRef

15.

Stromqvist B. Hip fracture in rheumatoid arthritis. Acta Orthop Scand. 1984;55:624–8.PubMedCrossRef

16.

Tyndall WA, Beam HA, Zarro C, O’Connor JP, Lin SS. Decreased platelet derived growth factor expression during fracture healing in diabetic animals. Clin Orthop Relat Res 2003;408:319–30.PubMedCrossRef

17.

Kolar P, Gaber T, Perka C, Duda GN, Buttgereit F. Human early fracture hematoma is characterized by inflammation and hypoxia. Clin Orthop Relat Res. 2011. Epub ahead of print.

18.

Busti AJ, Hooper JS, Amaya CJ, Kazi S. Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing. Pharmacotherapy. 2005;25:1566–91.PubMedCrossRef

19.

Chidrawar SM, Khan N, Chan YL, Nayak L, Moss PA. Ageing is associated with a decline in peripheral blood CD56bright NK cells. Immun Ageing. 2006;3:10.PubMedCrossRef

20.

Ishikawa M, Nishioka M, Hanaki N, Miyauchi T, Kashiwagi Y, Kawasaki Y, Miki H, Kagawa H, Ioki H, Nakamura Y. Postoperative host responses in elderly patients after gastrointestinal surgery. Hepatogastroenterology. 2006;53:730–5.PubMed

21.

Smith RM. Immunity, trauma and the elderly. Injury. 2007;38:1401–4.PubMedCrossRef

22.

Woodland DL, Blackman MA. Immunity and age: living in the past? Trends Immunol. 2006;27:303–7.PubMedCrossRef

23.

Kang SC, Matsutani T, Choudhry MA, Schwacha MG, Rue LW, Bland KI, Chaudry IH. Are the immune responses different in middle-aged and young mice following bone fracture, tissue trauma and hemorrhage? Cytokine. 2004;26:223–30.PubMedCrossRef

24.

Arason GJ, Jorgensen GH, Ludviksson BR. Primary immunodeficiency and autoimmunity: lessons from human diseases. Scand J Immunol. 2010;71:317–28.PubMedCrossRef

25.

Yu D, Vinuesa CG. Multiple checkpoints keep follicular helper T cells under control to prevent autoimmunity. Cell Mol Immunol. 2010;7:198–203.PubMedCrossRef

Titel: Immunologically restricted patients exhibit a pronounced inflammation and inadequate response to hypoxia in fracture hematomas
verfasst von: Paula Hoff
T. Gaber
K. Schmidt-Bleek
U. Sentürk
C. L. Tran
K. Blankenstein
S. Lütkecosmann
J. Bredahl
H. J. Schüler
P. Simon
G. Wassilew
F. Unterhauser
G. R. Burmester
G. Schmidmaier
C. Perka
G. N. Duda
F. Buttgereit
Publikationsdatum: 01.10.2011
Verlag: Humana Press Inc
Erschienen in: Immunologic Research / Ausgabe 1/2011
Print ISSN: 0257-277X
Elektronische ISSN: 1559-0755
DOI: https://doi.org/10.1007/s12026-011-8235-9

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Immunologically restricted patients exhibit a pronounced inflammation and inadequate response to hypoxia in fracture hematomas

Abstract

Neu im Fachgebiet HNO

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Nur selten Nachblutungen nach Abszesstonsillektomie

Rezidivierender Peritonsillarabszess nach Oralsex

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2011

Regulation of major histocompatibility complex class I molecule expression on cancer cells by amyloid precursor-like protein 2

Global study of primary immunodeficiency diseases (PI)—diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation

Activation of regulatory T cells instigates functional down-regulation of cytotoxic T lymphocytes in human breast cancer

Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily

Strategies for B-lymphocyte repertoire remodeling in transplantation tolerance

Antigenic specificity and expression of a natural idiotope on human pentameric and hexameric IgM polymers

Neu im Fachgebiet HNO

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Nur selten Nachblutungen nach Abszesstonsillektomie

Rezidivierender Peritonsillarabszess nach Oralsex

Update HNO